Literature DB >> 7273855

Evidence of clonal attenuation, clonal succession, and clonal expansion in mass cultures of aging Werner's syndrome skin fibroblasts.

D Salk, K Au, H Hoehn, M R Stenchever, G M Martin.   

Abstract

Skin fibroblast-like (FL) cells from patients with Werner's syndrome (adult progeria) demonstrate multiple, stable, structural chromosome rearrangements (variegated translocation mosaicism) which can be used to identify cytogenetically marked clones of cells within a mass culture. We have cytogenetically followed eight FL cell strains (from two patients) throughout their entire in vitro replicative lifespans, and we show a correlation between the expansion and attenuation of individual clones and the growth of the mass cultures. One strain, which was aged several times, demonstrated a generally reproducible pattern of clonal succession but, surprisingly, also demonstrated, in two parallel derivative cultures, the late emergence of two relatively rapidly growing clones that had not been observed in the parental culture. These observations suggest that clonal succession and clonal attenuation occur in mass cultures, as had been predicted on the basis of dilute-plating cloning experiments. Our results may have implications for models of in vitro cellular senescence. In addition, there are interesting parallels with the tissue hyperplasia associated with in vivo aging, and this observation is compatible with the suggestion that skin FL cells in vitro provide a model for hyperplasia in vivo.

Entities:  

Mesh:

Year:  1981        PMID: 7273855     DOI: 10.1159/000131597

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  21 in total

1.  Mutations in the WRN gene in mice accelerate mortality in a p53-null background.

Authors:  D B Lombard; C Beard; B Johnson; R A Marciniak; J Dausman; R Bronson; J E Buhlmann; R Lipman; R Curry; A Sharpe; R Jaenisch; L Guarente
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Recombination-mediated lengthening of terminal telomeric repeats requires the Sgs1 DNA helicase.

Authors:  H Cohen; D A Sinclair
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

3.  Scratching the Surface of Werner Syndrome and Human Ageing.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2017-11-23

Review 4.  Potential for pharmacological intervention in Werner syndrome.

Authors:  S Murano
Journal:  Drugs Aging       Date:  1995-12       Impact factor: 3.923

5.  Werner's syndrome: proliferation in vitro of clones of cells bearing chromosome translocations.

Authors:  S Schonberg; M F Niermeijer; D Bootsma; E Henderson; J German
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

6.  Accelerated telomere shortening and replicative senescence in human fibroblasts overexpressing mutant and wild-type lamin A.

Authors:  Shurong Huang; Rosa Ana Risques; George M Martin; Peter S Rabinovitch; Junko Oshima
Journal:  Exp Cell Res       Date:  2007-08-16       Impact factor: 3.905

7.  Effects of radical-scavenging enzymes and reduced oxygen exposure on growth and chromosome abnormalities of Werner syndrome cultured skin fibroblasts.

Authors:  D Salk; K Au; H Hoehn; G M Martin
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

8.  Telomere length regulates ISG15 expression in human cells.

Authors:  Zhenjun Lou; Jun Wei; Harold Riethman; Joseph A Baur; Regina Voglauer; Jerry W Shay; Woodring E Wright
Journal:  Aging (Albany NY)       Date:  2009-07-17       Impact factor: 5.682

9.  Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21.

Authors:  A Orr-Urtreger; L Trakhtenbrot; R Ben-Levy; D Wen; G Rechavi; P Lonai; Y Yarden
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

10.  Clonal structural chromosomal rearrangements in primary fibroblast cultures and in lymphocytes of patients with Werner's Syndrome.

Authors:  S Scappaticci; D Cerimele; M Fraccaro
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.